Skip to main content

Table 3 Baseline imaging characteristics: anatomic distribution of disease by patient

From: Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression

Anatomic sites of metastases

Visceral involvement (n, %)

No Visceral involvement (n, %)

Total patients

61 (30.1)

142 (70.0)

Bone only (BSLA and/or soft tissue bone)

0

80 (39.4)

Bone and lymph node

0

57 (28.1)

Bone and local recurrence

0

1 (0.5)

Bone, lymph node and local recurrence

0

3 (1.5)

Bone and visceral disease

27 (13.3)

0

Bone, lymph node and visceral

31 (15.3)

0

Bone, lymph node, local recurrence and visceral disease

2 (1.0)

0

Visceral disease and lymph node

1 (0.5)

0